Speaker illustration

Doctor Armenui Gasparyan

National Medical Research Center of Cardiology, Moscow (Russian Federation)

Specialist diploma with honors from Sechenov University (Moscow, Russia) in the specialty of General Medicine (2015). Diploma of a resident of the National Medical Research Center of Cardiology of the Ministry of Health of Russia (Moscow, Russia) with the qualification of a cardiologist (2017). Currently, I am a postgraduate student at the National Medical Research Center of Cardiology of the department of cardiac arrhythmias and conduction disorders. I study the predictive capabilities of biomarkers for the treatment of chronic heart failure and prevention of sudden cardiac death.

sST2 is a new potential predictor of the response to cardiac resynchronization therapy and of cardiac contractility modulation in patients with chronic heart failure

Event: Heart Failure 2021

Topic: Cardiac Resynchronisation Therapy (CRT)

Session: ePoster session


Dynamic changes of sST2 and NT-proBNP levels in responders and non-responders to cardiac resynchronization and cardiac contractility modulation therapies

Event: Heart Failure 2018

Topic: Biomarkers

Session: Chronic Heart Failure – Diagnostic Methods


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb